Ausgabe 6/2007
Inhalt (28 Artikel)
Genes harbouring susceptibility SNPs are differentially expressed in the breast cancer subtypes
Silje H Nordgard, Fredrik E Johansen, Grethe IG Alnæs, Bjørn Naume, Anne-Lise Børresen-Dale, Vessela N Kristensen
Genomics and premalignant breast lesions: clues to the development and progression of lobular breast cancer
Teresa L Mastracci, Fouad I Boulos, Irene L Andrulis, Wan L Lam
The promise and limitations of genome-wide association studies to elucidate the causes of breast cancer
Christine B Ambrosone
Serum epidermal growth factor receptor and HER2 expression in primary and metastatic breast cancer patients
Kristjan S Asgeirsson, Amit Agrawal, Claire Allen, Anthony Hitch, Ian O Ellis, Caroline Chapman, Kwok L Cheung, John FR Robertson
Identification of the functional role of peroxiredoxin 6 in the progression of breast cancer
Xin-Zhong Chang, Da-Qiang Li, Yi-Feng Hou, Jiong Wu, Jin-Song Lu, Gen-Hong Di, Wei Jin, Zhou-Luo Ou, Zhen-Zhou Shen, Zhi-Ming Shao
Decursin and decursinol angelate inhibit estrogen-stimulated and estrogen-independent growth and survival of breast cancer cells
Cheng Jiang, Junming Guo, Zhe Wang, Bingxiu Xiao, Hyo-Jung Lee, Eun-Ok Lee, Sung-Hoon Kim, Junxuan Lu
Osteoactivin/HGFIN: is it a tumor suppressor or mediator of metastasis in breast cancer?
April AN Rose, Peter M Siegel
The protective side of progesterone
Gianluigi Ferretti, Alessandra Felici, Francesco Cognetti
Clinical correlates of low-risk variants in FGFR2, TNRC9, MAP3K1, LSP1 and 8q24 in a Dutch cohort of incident breast cancer cases
Petra EA Huijts, Maaike PG Vreeswijk, Karin HG Kroeze-Jansema, Catharina E Jacobi, Caroline Seynaeve, Elly MM Krol-Warmerdam, Pauline M Wijers-Koster, Jannet C Blom, Karen A Pooley, Jan GM Klijn, Rob AEM Tollenaar, Peter Devilee, Christi J van Asperen
Signal transducer and activator of transcription 5b: a new target of breast tumor kinase/protein tyrosine kinase 6
Amanda M Weaver, Corinne M Silva
Inhibition of proteasome activity by the dietary flavonoid apigenin is associated with growth inhibition in cultured breast cancer cells and xenografts
Di Chen, Kristin R Landis-Piwowar, Marina S Chen, Q Ping Dou
International Web-based consultation on priorities for translational breast cancer research
Mitch Dowsett, Aron Goldhirsch, Daniel F Hayes, Hans-Joerg Senn, William Wood, Giuseppe Viale
Identification of BRCA1 missense substitutions that confer partial functional activity: potential moderate risk variants?
Paul K Lovelock, Amanda B Spurdle, Myth TS Mok, Daniel J Farrugia, Sunil R Lakhani, Sue Healey, Stephen Arnold, Daniel Buchanan, kConFab Investigators, Fergus J Couch, Beric R Henderson, David E Goldgar, Sean V Tavtigian, Georgia Chenevix-Trench, Melissa A Brown
Are triple-negative tumours and basal-like breast cancer synonymous?
Emad A Rakha, David SP Tan, William D Foulkes, Ian O Ellis, Andrew Tutt, Torsten O Nielsen, Jorge S Reis-Filho
Identification of a novel truncating PALB2mutation and analysis of its contribution to early-onset breast cancer in French-Canadian women
William D Foulkes, Parviz Ghadirian, Mohammed Reza Akbari, Nancy Hamel, Sylvie Giroux, Nelly Sabbaghian, Andrew Darnel, Robert Royer, Aletta Poll, Eve Fafard, André Robidoux, Ginette Martin, Tarek A Bismar, Marc Tischkowitz, Francois Rousseau, Steven A Narod
Mammographic density, breast cancer risk and risk prediction
Celine M Vachon, Carla H van Gils, Thomas A Sellers, Karthik Ghosh, Sandhya Pruthi, Kathleen R Brandt, V Shane Pankratz
Adjuvant endocrine therapy for premenopausal women with early breast cancer
Ting Bao, Nancy E Davidson
Are triple-negative tumours and basal-like breast cancer synonymous? Authors' response
Bas Kreike, Marc J van de Vijver
Vitamin D receptor polymorphisms and breast cancer risk in a large population-based case-control study of Caucasian and African-American women
Britton Trabert, Kathleen E Malone, Janet R Daling, David R Doody, Leslie Bernstein, Giske Ursin, Polly A Marchbanks, Brian L Strom, Mariela C Humphrey, Elaine A Ostrander
Regulator of G-protein signalling 2 mRNA is differentially expressed in mammary epithelial subpopulations and over-expressed in the majority of breast cancers
Matthew J Smalley, Marjan Iravani, Maria Leao, Anita Grigoriadis, Howard Kendrick, Tim Dexter, Kerry Fenwick, Joseph L Regan, Kara Britt, Sarah McDonald, Christopher J Lord, Alan MacKay, Alan Ashworth
Anticlusterin treatment of breast cancer cells increases the sensitivities of chemotherapy and tamoxifen and counteracts the inhibitory action of dexamethasone on chemotherapy-induced cytotoxicity
Maximino Redondo, Teresa Téllez, Maria J Roldan, Alfonso Serrano, Maria García-Aranda, Martin E Gleave, Maria L Hortas, Miguel Morell
CD40 signaling predicts response to preoperative trastuzumab and concomitant paclitaxel followed by 5-fluorouracil, epirubicin, and cyclophosphamide in HER-2-overexpressing breast cancer
Francisco J Esteva, Jing Wang, Feng Lin, Jaime A Mejia, Kai Yan, Kadri Altundag, Vicente Valero, Aman U Buzdar, Gabriel N Hortobagyi, W Fraser Symmans, Lajos Pusztai
A prospective pilot clinical trial evaluating the utility of a dynamic near-infrared imaging device for characterizing suspicious breast lesions
Ronald X Xu, Donn C Young, Jimmy J Mao, Stephen P Povoski
Cytoplasmic location of factor-inhibiting hypoxia-inducible factor is associated with an enhanced hypoxic response and a shorter survival in invasive breast cancer
Ern Yu Tan, Leticia Campo, Cheng Han, Helen Turley, Francesco Pezzella, Kevin C Gatter, Adrian L Harris, Stephen B Fox
Recent breast cancer trends among Asian/Pacific Islander, Hispanic, and African-American women in the US: changes by tumor subtype
Amelia K Hausauer, Theresa HM Keegan, Ellen T Chang, Christina A Clarke
Effects of high-fat diet and/or body weight on mammary tumor leptin and apoptosis signaling pathways in MMTV-TGF-α mice
Soner Dogan, Xin Hu, Yan Zhang, Nita J Maihle, Joseph P Grande, Margot P Cleary